Research

Mixed

Primary Obesity Surgery Endoluminal (POSE) 2.0 and Endomina Gastric Plication are effective endoscopic gastric remodeling techniques that produce significant weight loss and metabolic improvements, though with varying efficacy profiles compared to ESG.

POSE 2.0 and Endomina are endoscopic options that use full-thickness plications to reduce stomach size. They are effective for weight loss and metabolic improvement, though ESG may offer higher weight loss percentages in some studies. They are suitable for patients seeking minimally invasive alternatives to surgery.

ModerateSupportsMEDIUM confidence
The initial result of the POSE 2.0 procedure with 73 obese patients showed a TWL of 15.7% at 6 months... An international multicenter randomized controlled study (INSPIRO trial) has recently been approved by the FDA... An initial multicenter prospective study involved 51 patients... who underwent Endomina gastric plication. After one year, the participants achieved a TWL of 7.4% and an EWL of 29%.
Stephen Ka Kei Ng et al. · Metabolism and Target Organ Damage · 2025

Why this rating

Supported by prospective studies and RCTs, but sample sizes are smaller than ESG cohorts, and long-term data is less extensive.

Source

Endoscopic gastric remodeling procedures for obesity treatment: a comprehensive review

Stephen Ka Kei Ng et al. · Metabolism and Target Organ Damage · 2025

DOI 10.20517/mtod.2024.112

narrative_reviewCited 3×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →